- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03533660
Alcohol Biosensor Monitoring for Alcoholic Liver Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with AALD followed at our liver disease clinic,
- 18 years or older,
- willing to accept randomization,
- and agree to wear device for 3 months,
- SOCRATES problem recognition subscale score >26 (scores <26 indicate very low recognition of an alcohol problem).
Exclusion Criteria:
- Non-English speaking,
- Montreal Cognitive Assessment (MOCA) scores <21 (moderate cognitive impairment) or neurologic diseases (e.g. Parkinson's),
- patients with unresponsive acute alcoholic hepatitis, multi-organ failure, fulminant hepatic failure,
- cancer/terminal illness;
- those unable to wear a wrist monitor (e.g., edema);
- lacking a residence, or unable to identify a contact person (if lost to follow-up).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Feedback
Participant will receive a brief feedback on data downloaded from the ABM and information about treatment resources
|
Participant will receive a brief feedback on alcohol use data downloaded from the ABM and information about treatment resources
|
Active Comparator: Enhanced usual care
Participant will receive information about remaining abstinent and about treatment resources
|
Participant will receive information on self reported alcohol use and information about remaining abstinent and about treatment resources
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol Use
Time Frame: continuous for up to 3 months
|
Average number of drinks per drinking episode per interval (month) of device wear.
We analyzed the number of drinks per drinking episode and present the group average per month interval of assessment.
|
continuous for up to 3 months
|
Percent of Days Drinking Per Interval of Device Wear
Time Frame: 3 months
|
Percent of days drinking per interval of device wear: We analyzed the data by number of drinking episodes per individual per days of device wear and present the mean percent days drinking per assessment interval
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improved Readiness for Alcohol Abstinence and Initiation of Change
Time Frame: Scores determined at initiation, 6 weeks and 3 months of participation
|
Stages of Change Readiness & Treatment Eagerness Scale (SOCRATES) is a 19-item instrument that measures readiness for change assessing three areas; ambivalence, recognition, and taking steps with change scores assessing the impact of an intervention on these areas. Three subscale scores are produced with total scores ranging 19-95 and higher score indicating greater readiness:
|
Scores determined at initiation, 6 weeks and 3 months of participation
|
Self Efficacy to Remain Abstinent
Time Frame: Scores determined at initiation, 6 weeks and 3 months of participation
|
Alcohol Abstinence Self-efficacy (AASE) evaluates confidence in ability to abstain from drinking in situations that represent typical drinking cues. Four subscales with 5 specific situations each are rated on confidence not to drink in each situations on a 5-point Likert scale from 1=not at all confident to 5=extremely confident. Total scores range from 20-100 with higher scores reflecting greater self confidence not to drink.
|
Scores determined at initiation, 6 weeks and 3 months of participation
|
Medical Outcomes
Time Frame: Counts determined at initiation, 6 weeks and 3 months of participation
|
AALD related hospitalizations and ER visits - total count of participants in each arm who experienced these outcomes
|
Counts determined at initiation, 6 weeks and 3 months of participation
|
Qualitative Interviews
Time Frame: measured at three months (completion of the participants use of ABM)
|
Qualitative interviews of participants will use a semi-structured script of open-ended stem questions with prompts.
The qualitative assessment will cover such topics as patients' perceived need/psychologic barriers (e.g., beliefs in value of ABM in their clinical care and for their relationship with clinicians) and experience with ABM (e.g., wearability, satisfaction, and barriers to monitoring).
Transcribed interviews will be thematically coded.
The constant comparison method will be used, and subsequent interviews may be modified/informed by findings from previous interviews to explore emerging themes as the analysis proceeds.
|
measured at three months (completion of the participants use of ABM)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andrea DiMartini, MD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21AA025730 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use, Unspecified
-
University of Rhode IslandCompletedAlcohol Use, UnspecifiedUnited States
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
University of Rhode IslandUniversity of TexasNot yet recruitingAlcohol Use, Unspecified
-
Zeno Functional Foods, LLCINQUIS Clinical Research Ltd.CompletedAlcohol Use, UnspecifiedCanada
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH); National Center for Complementary and...CompletedTobacco Use | Alcohol Use, UnspecifiedUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use, UnspecifiedUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Use, UnspecifiedUnited States
-
Virginia Commonwealth UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of Central FloridaCompleted
-
LifespanRecruitingAlcohol Use, Unspecified | Sexual AssaultUnited States
Clinical Trials on Feedback
-
University of MichiganEnrolling by invitationDepression | Anxiety | Sleep Disturbance | AddictionUnited States
-
University Hospital, CaenUnknown
-
Northwestern UniversityCompletedAutism Spectrum Disorder | AutismUnited States
-
University of North Carolina, Chapel HillNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAphasia | Cerebrovascular Accident | Apraxia of SpeechUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH); VA Connecticut Healthcare SystemTerminatedPost-Traumatic Stress DisorderUnited States
-
Albert Einstein College of MedicineNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Duke UniversityTerminatedFeeding Behavior | Diet Habit | Behavior, HealthUnited States
-
KEMRI-Wellcome Trust Collaborative Research ProgramCompleted